share

Spiro[4H-Cyclopent[C]Isoxazole-4,2-Imidazolidine] (9Ci) CAS NO 300380-93-2


Unit Price:

CAS No.:300380-93-2

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Spiro[4H-Cyclopent[C]Isoxazole-4,2-Imidazolidine] (9Ci) is a complex spirocyclic organic compound featuring fused isoxazole and imidazolidine rings, representing a valuable scaffold in advanced chemical synthesis. This compound matters as a sophisticated pharmacophore and chemical intermediate for developing novel active ingredients with potential biological activity. It is primarily needed by pharmaceutical R&D teams and agrochemical innovators seeking to explore new molecular entities for drug discovery and crop protection applications.

Application

  • Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders or infectious diseases.
  • Agrochemical Research: Used as a precursor in developing new-generation herbicides, fungicides, or insecticides with unique modes of action.
  • Chemical Biology Probe: Acts as a scaffold for creating tool compounds to study enzyme function or protein-protein interactions in biological systems.
  • Material Science Research: Potential intermediate for synthesizing specialty polymers or ligands with specific electronic or coordination properties.
  • Academic & Contract Research: Employed in university and CRO laboratories for methodological studies in heterocyclic and spirocyclic chemistry.

Basic Information

Product Name Spiro[4H-Cyclopent[C]Isoxazole-4,2-Imidazolidine] (9Ci)
CAS No. 300380-93-2
Molecular Formula C6H8N2O
Molecular Weight 124.14 g/mol
Synonyms Spiro[4H-cyclopent[c]isoxazole-4,2-imidazolidine]; 4H-Cyclopent[c]isoxazole, hexahydro-2-imino-, (4R,4aR,7aS)-isomer; 4H-Cyclopent[c]isoxazole, hexahydro-2-imino-; Spiro(cyclopent[c]isoxazole-4(1H),2'-imidazolidine); 300380-93-2; Spirocyclopentisoxazoleimidazolidine; (4R,4aR,7aS)-Hexahydro-2-imino-4H-cyclopent[c]isoxazole
EINECS Contact for details

Quality Control

Our Spiro[4H-Cyclopent[C]Isoxazole-4,2-Imidazolidine] (9Ci) is produced under a strict quality management system. Each batch undergoes rigorous analytical testing, including HPLC for purity and NMR/IR for structural confirmation, to ensure it meets the high standards required for research and development. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are available upon request to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed when not in use to protect from moisture.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 95.0%
Water Content ≤ 1.0%
Residue on Ignition ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.